Lenz Therapeutics, Inc. (LENZ) — 4 Filings
All 4 filings from Lenz Therapeutics, Inc.. Browse 3 Insider Trade reports with AI-powered summaries and risk analysis.
4 Filings (3)
-
LENZ Therapeutics Files Form 4
— Mar 30, 2026 Risk: low
On March 27, 2026, LENZ Therapeutics, Inc. (CIK: 0001815776) filed a Form 4 with the SEC, reporting changes in beneficial ownership of securities. The filing wa -
PFENEX INC. Reports Ownership Change for LENZ Therapeutics
— Mar 30, 2026 Risk: low
On March 27, 2026, Evert B. Schimmelpennink, a reporting person for PFENEX INC., reported a change in beneficial ownership of securities related to LENZ Therape -
LENZ Therapeutics Files Form 4 on Ownership Changes
— Mar 30, 2026 Risk: low
On March 30, 2026, LENZ Therapeutics, Inc. filed a Form 4, indicating a statement of changes in beneficial ownership of securities. The report covers the period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX